2022 Financial Guidance slide image

2022 Financial Guidance

The Nation's #2 Partner in Radiation Therapy Services with Hospitals AKUMIN ~2/3 of cancer patients receive radiation therapy as part of their cancer treatment Akumin specializes in radiation therapy modalities and related services treating some of the most common primary cancers (breast, lung, prostate) as well as metastatic disease More than 10,000 patients treated annually • Akumin excels in Joint Venture partnerships with hospitals and physicians and in delivering this complex clinical service line • 22 Joint Ventures • 35 Sites of Care • Two Interim Radiation Therapy Systems Patient starts recovered to pre-pandemic levels 10,459 Total Patient Starts/Year (Pro Forma) 10,161 10,564 $12,289 Revenue/Start Per Year (Pro Forma) $12,489 $12,513 FY2019 FY2020 Q3'21 TTM FY2019 FY2020 Q3'21 TTM 10
View entire presentation